MedTrace Logo

Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC

NCT05176067 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2022-01-04

No results posted yet for this study

Summary

To investigate whether radiotherapy combined with drug therapy is beneficial to non- oligometastatic stage IV NSCLC

Conditions

  • Stage IV Non-small Cell Lung Cancer

Interventions

RADIATION

Thoracic Three-dimensional Radiotherapy

Drug Therapy Combined With Thoracic Three-dimensional Radiotherapy

Sponsors & Collaborators

  • Guizhou Medical University

    lead OTHER

Principal Investigators

  • Bing Lu, bachelor · Department of thoracic oncology, Affiliated Cancer Hospital of Guizhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-30
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05176067 on ClinicalTrials.gov